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ABSTRACT The genetic stability of every living organism depends on accurate DNA
replication and repair systems. Here, we investigated the Aspergillus fumigatus MSH2
mismatch repair (MMR) gene MshA and how it impacts virulence and the evolution
of azole resistance. We examined mshA gene variation in 62 environmental and clini-
cal A. fumigatus strains. We have observed 12 strains with variants (18.2%), and 8
strains among them showed missense variants. We demonstrated that A. fumigatus
mshA null mutants are haploid and have conserved karyotypes with discrete gross
chromosomal rearrangements. The ΔmshA strains are not sensitive to several DNA-
damaging agents. The lack of mshA caused a significant reduction of virulence of A.
fumigatus in a neutropenic murine model of invasive pulmonary aspergillosis and in
the invertebrate alternative model Galleria mellonella. Wild-type and ΔmshA popula-
tions did not show any significant changes in drug resistance acquisition after they
were transferred 10 times in minimal medium in the absence of any stress. However,
these populations rapidly acquired virulence in the ΔmshA background and high lev-
els of resistance to posaconazole in the presence of this drug (at least 200-fold-
higher levels of resistance than those derived from the wild-type strain). Taken to-
gether, these results suggest that genetic instability caused by ΔmshA mutations can
confer an adaptive advantage, mainly increasing posaconazole resistance and viru-
lence acquisition.
IMPORTANCE Invasive aspergillosis (IA) has emerged as one of the most common
life-threatening fungal diseases in immunocompromised patients, with mortality
rates as high as 90%. Systemic fungal infections such as IA are usually treated with
triazoles; however, epidemiological research has shown that the prevalence of azole-
resistant Aspergillus fumigatus isolates has increased significantly over the last de-
cade. There is very little information about the importance of genomic stability for
A. fumigatus population structure, azole resistance, and virulence. Here, we decided
to investigate whether the mismatch repair system could influence A. fumigatus
azole resistance and virulence, focusing on one of the components of this system,
MSH2. Although the mutation frequency of mshA (the A. fumigatus MSH2 homo-
logue) is low in environmental and clinical isolates, our results indicate that loss of
mshA function can provide increased azole resistance and virulence when selected
for. These results demonstrate the importance of genetic instability in A. fumigatus
as a possible mechanism of evolving azole resistance and establishing fitness in the
host.
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Aspergillus fumigatus causes several clinical diseases, including the life-threateningdisease invasive pulmonary aspergillosis (IA), with high mortality rates in neutro-
penic patients (1–4). Systemic fungal infections such as IA are usually treated with
antifungal drugs such as polyenes, azoles, and echinocandins, the first two targeting
cell membrane ergosterol biosynthesis and the latter perturbing the biosynthesis of the
cell wall polysaccharide glucan (5). Echinocandins represent a relatively new class of
antifungal agents which act by noncompetitively, inhibiting the cell wall enzyme
-1,3-glucan synthase and therefore impairing fungal cell wall biosynthesis and integ-
rity (6). Echinocandins present fungistatic activity against Aspergillus spp. and are
regularly used as second-line therapy for treatment of IA (7). Triazole resistance is
becoming a major concern in A. fumigatus, and it has already been observed in six of
the seven continents. Resistance can evolve through exposure to azole compounds
during azole therapy or in the environment (8). Mutations in the cyp51A gene, whose
protein product is targeted by azoles, represent the main mechanism of resistance (9);
however, other known and unknown resistance mechanisms may be present (9).
Genetic stability is essential for the survival and maintenance of living organisms.
DNA mismatch repair (MMR) is a system for recognizing and repairing erroneous
insertion, deletion, and misincorporation of bases that can arise during DNA replication
and recombination, as well as repairing some forms of DNA damage (10, 11). Evolution
of fungal drug resistance has been associated with MMR (12–15). Drug resistance arises
more rapidly in Candida albicans strains lacking MMR proteins or proteins central to
double-strand break repair (12). Comparison of mutation frequencies in deletion strains
of eight MMR genes in C. neoformans showed that the loss of three of them, MSH2,
MLH1, and PMS1, results in an increase in mutation rates, allowing rapid generation of
resistance to antifungal agents (13). Healey et al. (14) have previously demonstrated
that strains carrying mutations in Candida glabrata MMR gene MSH2 exhibit a higher
propensity for breaking through antifungal treatment in vitro and in mouse models of
colonization. The mutator genotype was not associated with increases in fluconazole
resistance in C. glabrata isolates of a French cohort of patients harboring low rates of
resistance but was instead found to be related to rare and specific genotypes (16).
Absence of azole or echinocandin resistance was observed in C. glabrata isolates in
India despite a background prevalence of MMR-defective strains (17). In China, C.
glabrata bloodstream isolates showed that PDR1 multidrug transporter polymorphisms
were associated with acquisition of fluconazole resistance whereas MSH2 polymor-
phisms were not correlated with fluconazole resistance (18). It is possible that MMR
represents a partial explanation for the elevated rates of triazole and multidrug
resistance associated with C. glabrata (14, 15).
We previously investigated the A. fumigatus AtmA (Ataxia-telangiectasia mutated)
and AtrA kinases and how they impact virulence and the evolution of azole resistance
(19). We have observed that genetic instability caused by ΔatmA and ΔatrA mutations
can confer an adaptive advantage mainly in the intensity of voriconazole resistance
acquisition but not in virulence. Here, we investigated the influence of Msh2, a protein
that binds to DNA mismatches initiating the MMR, on A. fumigatus azole resistance. We
observed a low level of polymorphism in the mshA gene (here referred to as the A.
fumigatus MSH2 homologue) in A. fumigatus in clinical and environmental isolates. We
also constructed A. fumigatus mshA null mutants and demonstrated that the lack of
mutations in mshA could influence virulence in both a neutropenic murine model of
invasive pulmonary aspergillosis and in the moth Galleria mellonella as an alternative
animal model. We also demonstrated that different populations of the null mshA
mutants grown through 10 sequential mitotic passages can evolve virulence attributes
in the G. mellonella model of infection. We also observed that MshA plays an important
role in the development of increased azole resistance in A. fumigatus.
RESULTS
A. fumigatus MSH2 homolog (mshA) has low levels of genetic polymorphism in
clinical and environmental isolates. Saccharomyces cerevisiae Msh2p was used as a
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query to identify the orthologue A. fumigatus 3g09850 (Afu3g09850; here named MshA)
(E value, 00; identity, 46.7%; similarity, 64.7%). A. fumigatus mshA encodes a putative
protein with 940 amino acids and a molecular weight of 105.3 kDa. The organization of
protein domains analyzed by using the SMART interface (http://smart.embl-heidelberg
.de/) showed that the structure and organization of the A. fumigatus protein are highly
conserved compared to those of S. cerevisiae Msh2p (Fig. 1A). MshA has the following
domains: MutS_I (N terminus; 4.3E17; IPR007695), amino acids 13 to 125; MutS_II
(connector domain; 1E20; IPR007860), amino acids 140 to 284; MuTSd (core; DNA-
binding domain of DNA mismatch repair MUTS family; 5.68E105; IPR007696), amino
acids 314 to 639; MUTSac (C terminus; ATPase domain of DNA mismatch repair MUTS
family; 1.61E118; IPR000432), amino acids 656 to 857.
We examined mshA variation in 62 environmental and clinical A. fumigatus strains
(for a description of these strains, see reference 20). Determination of genome-wide
variation relative to the Af293 strain revealed 12 strains (18.2%) with 4 variants in the
5= and 3= untranslated regions (UTR), 13 strains with variants in the coding region (8
missense and 4 synonymous variants), and 7 strains with intergenic variants (Table 1;
see also Table S1 in the supplemental material). Eight strains (12.1%) showed missense
variants: 3 strains with Glu812Gly changes (domain affected, IPR007696), 3 strains with
Ala45Thr and Pro329Thr changes (domains affected, IPR007695 and IPR007696, respec-
tively), and 2 strains with Glu467Asp (domain affected, IPR000432) (Fig. 1A) (Table 1; see
also Table S1).
The mshA gene does not have a high missense substitution rate across strains. We
counted all missense mutations per gene across all strains, calculated the number of
missense SNPs per base pair per gene, and ranked them. There were 8,860 protein-
coding genes in which we detected at least one missense mutation, and mshA ranked
as the 7,795th most commonly missense-substituted gene. Looking at missense SNPs
in the MO79587EXP strain, mshA is ranked as the 6,086th most commonly missense-
substituted gene in this strain.
The MO79587EXP strain does not have an elevated rate of nonsynonymous substi-
tution relative to other strains, but it is part of a group of 3 strains that are more
divergent from Af293 than the remaining strains. These three strains have about twice
as many variants on average than the strains that are less divergent from Af293, and
this is true for all classes of variants, including missense and synonymous variants.
We also looked at the mutation rates in msh6 (Afu4g08300) and rad51 (Afu1g10410)
to see whether mshA had an unusual rate of substitution for a DNA repair gene. The
msh6 gene ranked as the 3,556th most frequently missense-substituted gene (of a total
of 8,860), and 59 strains had a missense substitution in this gene. However, 2 missense
substitutions in this gene are shared across 50 strains, so it is not likely that this gene
is frequently mutating but rather that the Af293 allele is uncommon in this set of
strains. There was only 1 observed missense variant in the rad51 gene in one strain.
These findings suggest that mshA is not an uncommonly frequent target of genetic
change in A. fumigatus.
Although we were able to download all the genome sequences from public
databases, despite several efforts and requests for access to these strains, we were
unable to obtain them. Thus, we conducted our analyses only on the MO79587EXP
clinical isolate, which was previously characterized by us (20). Sanger sequencing
validated the two point mutations in this strain in comparison to the Af293 strain
(Fig. 1A and C). The MO79587EXP strain showed the same resistance to methyl
methanesulfonate (MMS), 4-nitroquinoline oxide (4-NQO), and camptothecin (CPT),
posaconazole, voriconazole, and caspofungin as the wild-type strain (Fig. 1D and data
not shown).
Molecular and functional characterization of A. fumigatus MSH2 orthologue
MshA. We targeted mshA for deletion of the entire gene, aiming to further investigate
its role in A. fumigatus (see Fig. S1 in the supplemental material). To eliminate the
possibility of the occurrence of likely secondary mutations during the construction of
deletion strains, we selected two independent transformants from each deletion ex-
Aspergillus fumigatus MSH2 Homologue
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FIG 1 Genetic polymorphism of mshA in 62 A. fumigatus clinical and environmental isolates. (A) Organi-
zation of MshA as predicted using the SMART interface (http://smart.embl-heidelberg.de/). MshA has the
(Continued on next page)
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periment to pursue all our phenotypic analyses. First, we investigated whether the
mshA null mutations had caused any effect on ploidy and chromosome (Chr) rear-
rangement (Fig. 2; see also Fig. 3). Fluorescence-activated cell sorting (FACS) analysis
was used to compare the ploidy levels of the wild-type and mutant conidia (Fig. 2).
Haploid and diploid strains of A. nidulans were used as controls for known cellular DNA
content (Fig. 2). The Af293 wild-type parental and ΔmshA-1 and ΔmshA-2mutant strains
showed levels of DNA content consistent with a haploid distribution pattern, suggest-
ing that the mshA mutations had not affected the ploidy (Fig. 2).
As previously described (19), the karyotype of the A. fumigatus wild type is com-
posed of five chromosome-sized bands distributed as follows: three megabase bands
of 5.7, 4.9, and 3.9 Mb; two middle-sized bands of 2.2 and 1.8 Mb (Fig. 3). The karyotype
of mutants showed numerical and length-related chromosome polymorphisms com-
prising 4 megabase bands; the largest ones were of the same length (5.7 Mb) as the
wild type, 3 others were slightly shorter (4.6, 4.1, and 3.6 Mb), and one had a middle-
sized band of length 2.0 Mb. There was little (400 kb) variation in chromosome size
between the wild type and mutants. The gross chromosomal rearrangements may have
been the result of recombination events such as deletion, segmental duplication, and
interchromosome fusion-fission. For instance, the 4.6-Mb band found in the mutants
may have been generated from an 300-kb deletion in the 4.9-Mb band of the wild
type. The loss of 2.2-Mb and 1.8-Mb bands and the simultaneous appearance of the
2.0-Mb band in the mutants may be explainable by events of deletion and segmental
duplication in the 2.2-Mb and 1.8-Mb bands, respectively. Another explanation could be
that fusion of the chromosomes occurred following fission into two smaller chromo-
somes of the same size (2.0 Mb). The chromosomal band of 1.0 Mb detected in all of
the isolates may be related to minichromosomes described previously in strains and
progeny of crosses of several fungal species (21).
We have assigned the in silico chromosomes (Chr1 to Chr8) of A. fumigatus Af293 to
the chromosomal bands separated by pulsed-field gel electrophoresis (PFGE) (19).
In the wild type, each chromosomal band is associated with only one chromosome,
with the exception of the 3.9-Mb band, which harbors four in silico chromosomes (Chr3,
Chr4, Chr5, and Chr6). In themshAmutants, chromosomes 1 and 2 were assigned to the
bands of 5.7 Mb and 4.6 Mb, respectively; Chr3, Chr4, and Chr5 to the 4.1-M band; Chr6
to 3.6-Mb band; and Chr7 and Chr8 to a single band of 2.0 Mb. Comparison of the
karyotypic profiles of the wild type and mutants suggests that most of the chromo-
somal rearrangements were related to DNA loss. The genome of the mutants, estimated
on the basis of the size of the chromosomal bands, is 11.4% smaller than that of the
FIG 1 Legend (Continued)
following domains: MutS_I (N terminus; 4.3E17; IPR007695), amino acids 13 to 125; MutS_II (connector
domain; 1E20; IPR007860), amino acids 140 to 284; MuTSd (core; DNA-binding domain of DNA mismatch
repair MUTS family; 5.68E105; IPR007696), amino acids 314 to 639; MUTSac (C terminus; ATPase domain
of DNA mismatch repair MUTS family; 1.61E118; IPR000432), amino acids 656 to 857. (B) Phylogenetic tree
for the mshA gene showing the single nucleotide polymorphisms (SNPs) in amino acid predictions. (C)
Chromatograms (from Sanger method for DNA sequencing) of a small region of the mshA gene from strains
Af293 and MO79587EXP showing the SNPs. (D) A. fumigatus Af293 and MO79587EXP conidia (1  104) were
inoculated on MM with different drug concentrations. Plates were incubated for 5 days at 37°C. The results
were expressed as averages of radial diameter of the treatment area divided by the radial diameter of the
control from three independent experiments  standard deviations. MMS, methyl methanesulfonate;
4-NQO, 4-nitroquinoline oxide; CPT, camptothecin.
TABLE 1Missense mutations observed in A. fumigatus environmental and clinical isolates
Strain containing
variant




MO79587EXP 133 GA Ala45Thr
MO79587EXP 985 CA Pro329Thr
F16134 1401 GC Glu467Asp
08-31-08-91 2435 AG Glu812Gly
Aspergillus fumigatus MSH2 Homologue
July/August 2019 Volume 4 Issue 4 e00416-19 msphere.asm.org 5
 on O


















wild type, which indicates a loss of 3.3 Mb. It remains to be determined if this loss is
restricted to only some areas of the genome, such as subtelomeric regions. Resequenc-
ing of mutants and mapping back to the wild type could address this issue. In
agreement with the FACS analysis, these results strongly suggest that chromosomal
rearrangements found in null mutants did not affect the ploidy, with a small reduction
of DNA content in the mutants.
We evaluated the impact of several DNA-damaging agents on the growth of the
wild-type and mutant strains (Fig. 4). The mshAmutants showed the same resistance to
CPT and MMS as the wild-type strain (Fig. 4), but they were more resistant to 4-NQO
than the wild-type strain (Fig. 4B).
In vivo analysis of the influence of A. fumigatus mshA on virulence. In the
neutropenic murine model of IA, infection by the wild type strain, mutant ΔmshA-1, and
mutant ΔmshA-2 resulted in 90%, 30%, and 60% mortality 15 days postinfection,
respectively (Fig. 5A). The levels of ΔmshA-1 and ΔmshA-2 virulence were attenuated
compared to the levels seen with the wild-type strain according to the Mantel-Cox and
Gehan-Brestow-Wilcoxon tests (Fig. 5A; P values of 0.05). We also tested the virulence
of the MO79587EXP clinical isolate (which harbors two point mutations corresponding
to Ala45Thr and Pro329Thr; Fig. 1C) in comparison to that of the Af293 strain (Fig. 5B).
The MO79587EXP clinical isolate showed significant reduced virulence according to the
Mantel-Cox and Gehan-Brestow-Wilcoxon tests (P values of 0.05) compared to an-
other clinical isolate, namely, the Af293 strain (100% and 40% mortality, 7 and 16 days
postinfection, for Af293 and in MO79587EXP, respectively) (Fig. 5B).
In another set of experiments, we used the moth Galleria mellonella as an alternative
animal model to compare the levels of virulence of the mutants and the wild type. Both
the ΔmshA-1 and ΔmshA-2 mutants showed significantly reduced virulence according
to the Mantel-Cox and Gehan-Brestow-Wilcoxon tests (P values of 0.05) compared to
FIG 2 Fluorescence-activated cell sorting (FACS) analysis of A. nidulans and A. fumigatus DNA content.
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the wild-type strain (100%, 10%, and 50% mortality 7 and 10 days postinfection for the
wild-type strain, ΔmshA-1 mutant, and ΔmshA-2 mutant, respectively; Fig. 5C). These
data suggest that, compared to the wild-type strain, the lack of mutations in mshA
could influence virulence in A. fumigatus.
We verified whether sequential mitotic divisions of the wild-type strain and the
ΔmshA-1 and ΔmshA-2mutant strains without selective pressure would have an impact
on virulence. First, we established three independent populations for each strain
(wild-type A [WTA], WTB, and WTC populations; mutant ΔMSHA-1A, ΔMSHA-1B, and
ΔMSHA-1C populations; and mutant ΔMSHA-2A, ΔMSHA-2B, and ΔMSHA-2C popula-
tions). We then transferred these populations through 10 conidial passages from each
strain, except the parental ones, on MM plates and grew the populations at 37°C
without any selective pressure. These evolved strains have shown the same phenotypes
related to growth, conidiation, and sensitivity to DNA damage agents as those from the
original parental strains (data not shown). We also have not observed major chromo-
FIG 3 Karyotype polymorphism between wild-type strain and ΔmshA mutants of A. fumigatus. (A) Chromosomal
bands separated by PFGE and stained with ethidium bromide. The gel on the left shows the chromosome profile
of the A. fumigatus wild type. The profiles of the mutants were obtained in another gel shown at the right side of
the figure panel (see the raw image in Fig. S2). The A. fumigatus wild type and mutants have five chromosomal
bands. The smallest band (1.0 Mb) seen in the wild type and mutants might correspond to a minichromosome.
S. pombe and S. cerevisiae chromosomal bands were used as size standards indicated in megabases (Mb). (B)
Diagrammatic representation of karyotypes of the A. fumigatus wild type and mutants. The rectangles represent a
unique distinguishable band visualized after staining with ethidium bromide. The thickness of the rectangles
represents the proportional level of staining of each chromosomal band. The in silico chromosomes of A. fumigatus
assigned to the chromosomal bands are indicated at the left.
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somal differences among mutant ΔmshA-1, mutant ΔmshA-2, and 10th-passage strains
Δmsh-1A and Δmsh-2A (Fig. 3). Conidia of the wild-type strain and the corresponding
last-transferred populations were compared with respect to virulence by inoculating
them in G. mellonella larvae. In the G. mellonella model, infection of all the strains
resulted in 80% to 100% mortality at 7 to 10 days postinfection (Fig. 6A). There were no
statistically significant differences among the strains (Mantel-Cox and Gehan-Brestow-
Wilcoxon, P values of 0.05). Among the members of the ΔMSHA-1A, ΔMSHA-B, and
ΔMSHA-C populations and the ΔMSHA-2A, ΔMSHA-B, and ΔMSHA-C populations, only
members of the ΔMSHA-1A and ΔMSHA-2A populations were shown to be virulent
(with levels that were not significantly different from those measured for the wild-type
strain according to the Mantel-Cox and Gehan-Brestow-Wilcoxon tests, P values of
0.05) (Fig. 6B and C). These results strongly indicate that the genetic instability caused
by the absence of MshA in A. fumigatus can evolve its virulence attributes in the G.
mellonella model of infection.
The influence of A. fumigatus mshA mutants on azole resistance. To examine
if the lack of MshA could have any effect on azole resistance, we determined the MICs
for voriconazole and posaconazole in the A. fumigatus wild-type, ΔmshA-1, and
ΔmshA-2 strains and found that they were 0.75 and 0.4 g/ml, respectively (Table 2).
The MEC (minimal effective concentration) for caspofungin for all those strains was
0.125 g/ml (Table 2). Subsequently, we measured the posaconazole, voriconazole, and
caspofungin MICs and MECs in the populations that had previously been transferred 10
FIG 4 A. fumigatus ΔmshA mutants are not sensitive to DNA-damaging agents. A. fumigatus wild-type and ΔmshA
conidia (1  104) were inoculated on MM plus different drug concentrations. Plates were incubated for 5 days at
37°C. (A) CPT (camptothecin). (B) 4-NQO (4-nitroquinoline oxide). (C) MMS (methyl methanesulfonate).
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times in MM (Table 2). Only populations ΔmshA-1B and ΔmshA-1C showed an increased
voriconazole MIC (1.0 g/ml).
We also plated 108 conidia of the three original (without transfer) populations,
i.e., populations A, B, and C, for each strain on MM plus 0.3 g/ml of posaconazole
for 7 days at 37°C (Fig. 7A). Several colonies grew in each plate, and we isolated
three colonies from different populations (from the wild-type strain, two and one
colonies from populations B and C, respectively; from the ΔmshA-1 mutant, two
colonies and one colony from populations B and C, respectively; from the ΔmshA-2
mutant, three colonies from population B) (Fig. 7A). These colonies were streaked
once on MM plus 0.3 g/ml of posaconazole and centrally inoculated again on
MM plus 0.3 g/ml of posaconazole and allowed to grow for 10 days at 37°C. The
colonies derived from the ΔmshA-1 and ΔmshA-2 strains showed a much greater
number of sectors than those colonies derived from the wild-type strain, indicating
their increased genetic instability (Fig. 7B). Nevertheless, we also did not observe major
chromosomal differences among the ΔmshA-1 mutant, colony 3 derived from the
FIG 5 A. fumigatus mshA mutants have attenuated virulence in both a nutropenic mouse model and G. mellonella.
(A and B) Comparative analysis of wild-type and mutant strains in a neutropenic murine model of pulmonary
aspergillosis. Mice in groups of 10 per strain were infected intranasally with a 20-l suspension of conidia at a dose
of 105 conidia. (A) Percent survival of ΔmshA-1 and ΔmshA-2 mutants compared to the wild-type Af293 strain. (B)
Percent survival of MO79587EXP clinical isolate compared to the Af293 strain. (C) Comparative analysis of Af293
and mshA null mutants in G. mellonella animal model. Larvae in groups of 10 per strain were infected with a 5-l
suspension of conidia at a dose of 1  106/larva. PBS, phosphate-buffered saline.
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ΔmshA-1 mutant, and colony 3 derived from the Δmsh-2 mutant (Fig. 3). These strains
were also much more resistant to posaconazole, but to not voriconazole and caspo-
fungin, than their parental strains (Table 3). However, the strains derived from the
ΔmshA-1 and ΔmshA-2mutant strains were found to be at least 200-fold more resistant
than those derived from the wild-type strain (Table 3). These results strongly indicate
that Msh2 plays an important role in A. fumigatus genetic stability that dramatically
affects its drug resistance.
We also evaluated the effect of the selection of these strains on G. mellonella
virulence (Fig. 7C to E). The three colonies derived from the wild-type strain were found
FIG 6 The ΔmshAmutants recovered their virulence after several rounds of mitotic division. Results of comparative
analysis of the Af293, WTA-C, ΔmshA-1A to ΔmshA-1C, and ΔmshA-2A to ΔmshA-2C strains in the G. mellonella
animal model are shown. Larvae in groups of 10 per strain were infected with a 5-l suspension of conidia at a dose
of 1  106/larva. PBS, phosphate-buffered saline.
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to be less virulent than the wild-type strain (Fig. 7C). In contrast, colonies 2 and 3
derived from the ΔmshA-1 mutant became more virulent than the parental strain (and
even more virulent than the wild-type strain for colony 3) (Fig. 7D) and colonies 1 and
2 derived from the ΔmshA-2 strain became more virulent than the parental strain
(Fig. 7E).
Taken together, our results strongly suggest that Msh2 plays an important role for
A. fumigatus genetic stability and can dramatically impact drug resistance and virulence
of this pathogen.
DISCUSSION
MMR is a system for the correction of errors in which an incorrect base is incorpo-
rated into the daughter strand (22). MMR is essential for genomic stability, promoting
genomic fidelity by repairing base-base mismatches, insertion deletion loops, and
heterologies generated during DNA replication and recombination (22). S. cerevisiae
Msh2p recognizes DNA mismatches forming heterodimers with Msh3p and Msh6p
initiating the mismatch repair (23). The genomic instability favors the evolution of drug
resistance in the presence of the selecting conditions such as in the clinical environ-
ment, as has already been observed for several fungal species (12–15). Here, we
investigated the importance of MMR in A. fumigatus by screening a collection of
environmental and clinical isolates for mutations in MSH2 (here called mshA) and
constructing mshA deletion strains and assessing their role in drug resistance and
virulence.
We observed mshA variants in 18.2% of clinical and environmental A. fumigatus
isolates investigated, which contrasts with the 55% MSH2 variants in C. glabrata clinical
isolates reported previously (14). Interestingly, we observed three conserved spots of
variants in mshA that impact three different MshA domains. Phenotypic characteriza-
tion of one of these strains, MO79587EXP, which had had its genome previously
sequenced by our group (20), suggested that this strain’s phenotypic profile is com-
parable to that of the Af293 clinical isolate but that it has reduced virulence compared
to Af293, suggesting that mshA mutations could affect virulence. Actually, A. fumigatus
mshA null mutants have reduced virulence compared to their parental Af293 strain.
These results contrast with those determined for C. glabrata and C. neoformans MSH2
null mutants, which demonstrated levels of colonization and infection similar to those
seen with the corresponding wild-type strains (12, 13).
We grew the wild-type and mshA null mutants through 10 successive transfers on
solid medium. The rationale behind this experiment was to provide an opportunity for
the accumulation of mutations that could interfere with virulence and drug resistance.
There were no dramatic changes in the virulence and drug resistance profiles of three
independent populations of the wild-type strain. Interestingly, when the mshA null
mutants were transferred onto solid medium, some of the independent populations
gained virulence compared with the original null mutant. Considering that most of the




A. fumigatus WT (Af293) 0.75 0.4 0.125
A. fumigatus WT A 0.75 0.4 0.125
A. fumigatus WT B 0.75 0.4 0.125
A. fumigatus WT C 0.75 0.4 0.125
A. fumigatus ΔmshA-1 0.75 0.4 0.125
A. fumigatus ΔmshA-1 A 0.75 0.4 0.125
A. fumigatus ΔmshA-1 B 1 0.4 0.125
A. fumigatus ΔmshA-1 C 1 0.4 0.125
A. fumigatus ΔmshA-2 0.75 0.4 0.125
A. fumigatus ΔmshA-2 A 0.75 0.4 0.125
A. fumigatus ΔmshA-2 B 0.75 0.4 0.125
A. fumigatus ΔmshA-2 C 0.75 0.4 0.125
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July/August 2019 Volume 4 Issue 4 e00416-19 msphere.asm.org 11
 on O


















DNA damage effects observed when MMR genes are lacking are related to the
accumulation of nucleotide mutations, these results suggest that MMR defects in a
fungal population could be important drivers of the emergence of more-virulent
strains. Curiously, this was not observed with respect to drug resistance with either the
wild-type or null mutants, suggesting that the occurrence of MSH2mutations in clinical
isolates would favor the evolution of drug resistance under the conditions of strong
FIG 7 The wild-type and ΔmshA posaconazole-resistant mutants. (A) Conidia (1  108) from the three original (without transfer) populations (populations A,
B, and C) for each strain grown on MM plus 0.3 g/ml of posaconazole for 7 days at 37°C. (B) Isolated mutants from each population prepared as described for
panel A were subjected to point inoculation on MM plus 0.3 g/ml posaconazole for 10 days at 37°C. (C to E) Comparative analysis of Af293 and the mshA
and posaconazole-resistant mutants in the G. mellonella animal model. (C) Wild-type strains. (D) ΔmshA-1 strains. (E) ΔmshA-2 strains. Larvae in groups of 10
per strain were infected with a 5-l suspension of conidia at a dose of 1  106/larva. PBS, phosphate-buffered saline.
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drug selection normally present in the clinical environment. This is dramatically exem-
plified by the identification of azole-resistant mutants with high levels of posaconazole
resistance when the mshA null mutants were subjected to a single round of voricona-
zole exposure. Although we had also isolated posaconazole-resistant mutants derived
from the wild-type strains, those mutants were about 200-fold less sensitive to po-
saconazole than mshA null mutants. Surprisingly, the posaconazole-resistant mutants
derived from the wild-type strain lost their virulence whereas some of those derived
from mshA null mutants had gained virulence. Taken together, these results emphasize
the importance of MSH2 mutator phenotypes in the fitness of and in the establishment
of virulence of A. fumigatus.
Our results provide significant information about the influence of MSH2 mutations
on drug resistance and virulence in A. fumigatus. Additional work will focus on the
nature and the phenotypic effects of the mutations accumulated in these mutants that
allow A. fumigatus to gain drug resistance and increased virulence.
MATERIALS AND METHODS
Ethics statement. The principles that guide our studies are based on the Declaration of Animal
Rights ratified by UNESCO (articles 8 and 14) on 27 January 1978. All protocols adopted in this study were
approved by the local ethics committee for animal experiments from the University of São Paulo, Campus
of Ribeirao Preto (permit 08.1.1277.53.6 [Studies on the interaction of Aspergillus fumigatus with
animals]). Groups of five animals were housed in individually ventilated cages and were cared for in strict
accordance with the principles outlined by the Brazilian College of Animal Experimentation (COBEA) and
Guiding Principles for Research Involving Animals and Human Beings, American Physiological Society. All
efforts were made to minimize suffering. Animals were clinically monitored at least twice daily and
humanely sacrificed if moribund (defined by lethargy, dyspnea, hypothermia, and weight loss). All
stressed animals were sacrificed by cervical dislocation.
Strains, media, and growth conditions. The A. fumigatus parental strain used in this study was
strain Af293. All the constructed mutants were grown at 37°C in either minimal medium (MM; 1%
glucose, 50 ml of a 20 salt solution [120 g/liter NaNO3, 10.4 g/liter KCl, 30 g/liter KH2PO4, 10.4 g/liter
MgSO4] and 1 ml/liter of trace elements, pH 6.5) (24) or complete (yeast extract-glucose) medium {YG; 2%
glucose, 0.5% yeast extract, and 1 ml/liter of trace elements [22.0 g/liter ZnSO4, 11 g/liter boric acid, 5
g/liter MnCl2, 5 g/liter FeSO4, 1.6 g/liter CoCl2, 1.6 g/liter CuSO4, 1.1 g/liter (NH4)2MoO4, 50 g/liter
ethylenediaminetetraacetic acid]}. The media were made with and without 1% agar in order to obtain the
solid medium and liquid medium, respectively. Additionally, uridine and uracil (1.2 g/liter each) were
added as a nutritional supplement when necessary, resulting in YUU (YG plus UU) and MM plus UU
media, respectively. A list of the strains used in this study is provided in Table S2 in the supplemental
material.
Identification of the A. fumigatus MSH2 homolog and construction of the msh2 deletion
mutant. The A. fumigatus MSH2 gene was deleted through the gene replacement approach, and the
target gene was replaced with the pyrG prototrophic marker gene. The gene replacement cassette was
constructed by in vivo recombination in Saccharomyces cerevisiae (25). Briefly, the genomic DNA (gDNA)
of the Af293 strain was used as a template to PCR amplify 1 kb of the 5=-UTR and 1 kb of the 3=-UTR
flanking regions of the MSH2 gene, and those fragments were amplified using specific primer pairs P1/P2
and P3/P4, respectively (Table S3). In addition, the pyrG prototrophic marker was amplified from pCDA21
plasmid (primers P5 and P6) (Table S3). After PCR amplification and DNA purification (from an agarose
gel), the individual DNA fragments (the 5´UTR fragment, the 3´UTR fragment, and the pyrG marker
fragment) were cotransformed with the linearized BamHI/EcoRI pRS426 plasmid (into S. cerevisiae strain




WT (Af293) 0.75 0.4 0.125
WT colony 1 1 2 0.125
WT colony 2 1 2 0.125
WT colony 3 1 2 0.125
ΔmshA-1 0.75 0.4 0.125
ΔmshA-1 colony 1 0.75 400 0.125
ΔmshA-1 colony 2 0.75 400 0.125
ΔmshA-1 colony 3 0.75 400 0.125
ΔmshA-2 0.75 0.4 0.125
ΔmshA-2 colony 1 0.75 400 0.125
ΔmshA-2 colony 2 0.75 400 0.125
ΔmshA-2 colony 3 0.75 400 0.125
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FGSC SC9721) by the use of the lithium acetate method (25). The recombinant yeast candidates were
selected in solid YNB-URA medium (7 g/liter yeast nitrogen base without amino acids, 0.05 g/liter
histidine, 0.1 g/liter lysine, 0.1 g/liter leucine, 0.1 g/liter tryptophan, and 2% agar). In addition, the gDNA
of the yeast candidates was extracted, and the deletion cassettes were subjected to PCR amplification
using the outermost primers (P1 and P4) (Table S3). The gene replacement cassette was transformed into
the A. fumigatus Af293 pyrG-negative background strain (25, 26). All PCR amplifications were performed
using Phusion High-Fidelity DNA polymerase (New England Biolabs) or TaKaRa Ex Taq DNA polymerase
(Clontech). The A. fumigatus candidates that gave positive test results were purified in a selective medium
without uridine/uracil, and the gDNA was extracted and checked by Southern blotting using an AlkPhos
direct labeling and detection system (GE Healthcare Life Sciences), according to the protocol of the
manufacturer. Two independent transformants showing homologue integration of the deletion cassette
at the msh2 locus were selected for further analysis.
Measurements of DNA content per cell. Conidia were collected, centrifuged (13,000 rpm for 3 min),
and washed with sterile 1 phosphate-buffered saline (PBS) (8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, and
0.24 g KH2PO4 per liter of sterilized water). For cell staining, the protocol described previously by Almeida
et al. (27) was followed with modifications. Overnight fixation with 70% ethanol (vol/vol) was carried out
at 4°C. Following that step, conidia were harvested, washed, and suspended in 850 l of sodium citrate
buffer (50 mM sodium citrate; pH 7.5). Briefly, sonicated conidia were treated for 1 h at 50°C with RNase
A (Invitrogen, Waltham, MA, USA) (0.50 mg/ml) and for 2 h at 50°C with proteinase K (Sigma-Aldrich, St.
Louis, MO, USA) (1 mg/ml). Conidia were stained overnight with SYBR green (Invitrogen, Carlsbad, CA,
USA) (10,000) diluted 10-fold in Tris-EDTA (pH 8.0), at a concentration of 2% (vol/vol) at 4°C. Finally,
Triton X-100 (Sigma-Aldrich) was added to samples to reach a final concentration of 0.25% (vol/vol).
Stained conidia were analyzed in a FACS LSRII flow cytometer (Becton, Dickinson, NJ, USA) with a
488-nm-excitation laser. Signals from a minimum of 30,000 cells per sample were captured in the
fluorescein isothiocyanate (FITC) channel (530 nm  30 nm) at a low flow rate of about 1,000 cells/s, and
an acquisition protocol was defined to measure forward scatter (FSC) and side scatter (SSC) on a
4-decade logarithmic scale and green fluorescence (FITC) on a linear scale. FACS Diva was used as the
acquisition software. Results were analyzed with FlowJo software, version 10 (Tree Star), and with Modfit
LT software (Verity Software House, Topsham, ME).
Pulsed-field gel electrophoresis (PFGE) running conditions. The agarose blocks containing chro-
mosomal DNA from A. fumigatus isolates (wild-type strain and mutant strains) were submitted to
pulsed-field gel electrophoresis. Gene Navigator System (Pharmacia) was used under the conditions
described by Sasaki et al. (28), with minor modifications. The gels were prepared with Seaken agarose
(FMC Bioproducts) (1.1%)–1 TAE (Tris-acetate-EDTA) according to electrophoretic run protocol, with a
duration of 168 h and a constant voltage of 42 V at 10°C. The best electrophoretic resolution was
achieved with homogeneous pulses of 900 s for 24 h, 1,800 s for 24 h, 2,700 s for 48 h, 3,600 s for 48 h
and 4,500 s for 24 h, and the results were subjected to interpolation. Schizosaccharomyces pombe and S.
cerevisiae chromosomal DNA was used as the molecular size standard in each of the electrophoretic runs.
After this process, the gel was incubated in ethidium bromide solution (0.5 l/ml) for 30 min and
photographed under UV light.
Phenotypic characterization of the mshA null mutant. A total of 105 conidia of each strain tested
were grown in solid MM in presence or absence of various concentrations of camptothecin (CPT; 10 M,
25 M, 50 M, 75 M, and 100 M), methyl methanesulfonate (MMS; 0.005% and 0.02%), and
4-nitroquinoline-1-oxide (4-NQO; 0.1 g/ml and 1 g/ml). The plates were incubated for 120 h at 37°C,
and radial growth was measured. The radial growth in the presence of drugs of each strain was
normalized to the growth of each strain in MM without any drug. All plates were grown in triplicate, and
averages  standard deviations (SD) of the data are plotted.
MIC and minimal effective concentration (MEC) analysis. The drug susceptibility of the indicated
strains was assessed by using the MIC method or the minimal effective concentration (MEC) method (29).
The experiments were done in sterile 96-well plates containing 200 l of liquid MM (with or without
added antifungal drugs) plus 1  104 conidia/well. After 48 h of incubation at 37°C, the MICs of the
assayed drugs were determined visually as a no-growth endpoint. The MEC of caspofungin was defined
as the lowest drug concentration that led to the growth of small, rounded, compact microcolonies
compared to the growth control (caspofungin-free MM). The different drugs were diluted in the
following ranges: (i) caspofungin at 0 to 2 g/ml, (ii) voriconazole at 0 to 2 g/ml, and posaconazole at
0 to 400 g/ml. Three repetitions were performed for each treatment.
Virulence analysis of themshAmutants. (i) Murine model. The levels of virulence of the wild-type
strain, the msh2 null mutants, and the MO79587EXP clinical isolate were assayed through a murine
model of pulmonary aspergillosis using outbreed female mice (BALB/c strain; body weight, 20 to 22 g).
Briefly, the animals were housed in ventilated cages containing five mice each. For survival curve
analyses, the animal immunosuppression and infection were done according to a previously described
protocol (30). The statistical significance of the comparative survival values was calculated using the
Mantel-Cox test, Gehan-Brestow-Wilcoxon log rank analysis, and the Prism statistical analysis package.
(ii) Insect model. The levels of virulence of the wild-type strain and the msh2 null mutants and their
different populations were also analyzed using the larvae of G. mellonella obtained by breeding adult
moths (31). The larvae infection protocol was done according to the method reported previously by dos
Reis et al. (19).
Maintenance of genetic stability in the mshA mutants after sequential mitotic division. For the
sequential mitotic division performed in solid MM in the absence of stress, the wild-type strain and
mshA null mutants were divided into 3 independent populations each, resulting in a total of 9 different
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populations: the WTA, WTB, and WTC populations; the ΔmshA-1A, ΔmshA-1B, ΔmshA-1C populations; and
ΔmshA-2A, ΔmshA-2B, and ΔmshA-2C populations. Then, a total of 1  108 conidia from each of the
strains listed above were plated in solid MM and incubated 72 h at 37°C. The spores were harvested in
sterile water, washed twice, and plated again to reach a final concentration of 1  108 spores in MM
plates and were incubated for an additional 72 h at 37°C. The procedure described above was repeated
10 times for each strain. In the end of the process, a total of 9 evolved populations were obtained and
used for further assays.
Putative gains of azole resistance were also assayed by plating populations A, B, and C of the three
original strains (the wild-type strain and the mshA null mutant strains without transfer) in solid MM
supplemented with posaconazole. Briefly, the experimental design was developed as follows. A total of
108 conidia of original populations A to C of the wild-type and mshA-1 and mshA-2 mutant strains
were plated in a total of 9 plates in solid MM supplemented with 0.3 g/ml. All 9 plates were incubated
at 37°C for 7 days, and several resistant colonies emerged from them. Then, 3 colonies were selected from
each strain. Specifically, two colonies from population B and one colony from population C were selected
from the WT plates, two colonies from population B and 1 colony from population C were selected from
the mutant ΔmshA-1 plates, and, finally, three colonies from population B were selected from the mutant
ΔmshA-2 plates. All of the selected colonies were individually streaked in MM supplemented with
0.3 g/ml of posaconazole to increase the number of conidia, and the resulting reaction mixtures were
used for further assays.
Data availability. All strains constructed in this study are available upon request. All data necessary
for confirming the conclusions presented in the article are represented fully within the article.
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